Filing Details
- Accession Number:
- 0000905148-24-001095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 21:54:32
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 21:54:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835780 | Iii Titus Frazor Edmondson | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Acquisiton | 2024-04-01 | 2,671 | $16.72 | 22,676 | No | 4 | M | Direct | |
| American Depositary Shares | Acquisiton | 2024-04-01 | 830 | $16.72 | 23,506 | No | 4 | M | Direct | |
| American Depositary Shares | Disposition | 2024-04-02 | 675 | $16.15 | 22,831 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2024-04-02 | 210 | $16.15 | 22,621 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| American Depositary Shares | Stock Options (Right to Buy) | Acquisiton | 2024-04-01 | 84,663 | $0.00 | 84,663 | $16.72 |
| American Depositary Shares | Restricted Share Units | Acquisiton | 2024-04-01 | 55,031 | $0.00 | 55,031 | $0.00 |
| American Depositary Shares | Restricted Share Units | Disposition | 2024-04-01 | 2,671 | $0.00 | 2,671 | $0.00 |
| American Depositary Shares | Restricted Share Units | Disposition | 2024-04-01 | 830 | $0.00 | 830 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 84,663 | 2034-04-01 | No | 4 | A | Direct | |
| 55,031 | No | 4 | A | Direct | ||
| 8,013 | No | 4 | M | Direct | ||
| 1,660 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- ADSs acquired on vesting of Restricted Share Units.
- These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
- Each Stock Option is exercisable for one ADS, which represents ten Ordinary Shares of the issuer.
- The option vests in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service.
- Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
- The RSUs vest in equal annual installments over four years beginning on 04/01/2025, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting.
- The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
- The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
Billionaire Hedge Funds
